<DOC>
	<DOC>NCT00366236</DOC>
	<brief_summary>The purpose of this study is to determine the effect of nitazoxanide tablets in treating diarrhea caused by Entamoeba histolytica in adults and adolescents.</brief_summary>
	<brief_title>Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Amebiasis</mesh_term>
	<mesh_term>Dysentery, Amebic</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Age ≥12 years. Patients with diarrhea (≥3 bowel movements/day) with one or more enteric symptoms such as bloody stools, rectal bleeding or enlarged colon. Positive stool ELISA test for Entamoeba histolytica within 7 days prior to enrollment. Patients with identified causes of diarrhea other than E. histolytica. Use within 2 weeks of enrollment of any drug or therapy with possible antiprotozoal activity. Females who are pregnant, suspected of being pregnant or breastfeeding. Serious systemic disorders incompatible with the study. History of hypersensitivity to nitazoxanide. Patients in whom the possibility of receiving placebo and not being able to receive immediately an effective treatment will be incompatible with the severity of the patient's illness. Patients with amebic liver abscess. Patients known to have or suspected of having AIDS. Patient with immune deficiencies.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Amebiasis</keyword>
	<keyword>Entamoeba histolytica</keyword>
</DOC>